Balance Sheet Peptron, Inc.

Equities

A087010

KR7087010005

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
52,500.00 ^KRW	+11.70%		+15.64%	+30.43%

2023	Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal	MT
2023	Tranche Update on Peptron, Inc.'s Equity Buyback Plan announced on April 5, 2023.	CI

4df67.JOPZD-h9yj24UFKpSvJX70GM9yqX3HaHkO4wpmPAM34.UtTuNo1Q_ErvPCTfHrQBoAvLzn79lC7X85ZV7zaMd0YWs79oi0mpbegcMQ

Published financial data: PEPTRON, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	1.8B	3.12B	6.62B	5.81B	3.34B
Other Revenues, Total	-10	10	10	-	-
Total Revenues	1.8B	3.12B	6.62B	5.81B	3.34B
Cost of Goods Sold, Total	1.23B	2.11B	2.16B	2.54B	2.29B
Gross Profit	567M	1.01B	4.47B	3.27B	1.05B
Selling General & Admin Expenses, Total	3.24B	4.19B	5B	4.86B	5.21B
Provision for Bad Debts	526K	-	-	-	-
R&D Expenses	9.84B	14.18B	14.84B	13.37B	11.44B
Depreciation & Amortization - (IS)	103M	151M	177M	168M	163M
Amortization of Goodwill and Intangible Assets - (IS)	90.5M	93.13M	102M	101M	118M
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	13.27B	18.62B	20.12B	18.5B	16.94B
Operating Income	-12.7B	-17.61B	-15.66B	-15.23B	-15.88B
Interest Expense, Total	-	-	-36.84M	-280M	-396M
Interest And Investment Income	425M	141M	475M	423M	242M
Net Interest Expenses	425M	141M	439M	143M	-154M
Currency Exchange Gains (Loss)	17.78M	7.95M	192M	192M	96.06M
Other Non Operating Income (Expenses)	-5.37B	-705M	-244M	-685K	1.75M
EBT, Excl. Unusual Items	-17.63B	-18.16B	-15.27B	-14.89B	-15.94B
Gain (Loss) On Sale Of Investments	101K	-	5.28M	7.1M	2.83M
Gain (Loss) On Sale Of Assets	2M	-1K	-913K	-162M	3.47M
Asset Writedown	-1K	-173M	-15.96M	-19.49M	-7.05M
EBT, Incl. Unusual Items	-17.63B	-18.34B	-15.28B	-15.07B	-15.94B
Income Tax Expense	91.42M	46.81M	-242M	-4.21M	-18.94M
Earnings From Continuing Operations	-17.72B	-18.38B	-15.04B	-15.06B	-15.92B
Net Income to Company	-17.72B	-18.38B	-15.04B	-15.06B	-15.92B
Net Income - (IS)	-17.72B	-18.38B	-15.04B	-15.06B	-15.92B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-17.72B	-18.38B	-15.04B	-15.06B	-15.92B
Net Income to Common Excl. Extra Items	-17.72B	-18.38B	-15.04B	-15.06B	-15.92B
Per Share Items
Net EPS - Basic	-1.16K	-1.2K	-729.24	-730.25	-773.61
Basic EPS - Continuing Operations	-1.16K	-1.2K	-729.24	-730.25	-773.61
Basic Weighted Average Shares Outstanding	15.33M	15.37M	20.63M	20.63M	20.58M
Net EPS - Diluted	-1.16K	-1.2K	-729.24	-730.25	-773.61
Diluted EPS - Continuing Operations	-1.16K	-1.2K	-729.24	-730.25	-773.61
Diluted Weighted Average Shares Outstanding	15.33M	15.37M	20.63M	20.63M	20.58M
Normalized Basic EPS	-718.86	-738.53	-462.75	-451.24	-484.06
Normalized Diluted EPS	-718.86	-738.53	-462.75	-451.24	-484.06
Supplemental Items
EBITDA	-10.05B	-14.34B	-12.15B	-10.17B	-12.99B
EBITA	-12.55B	-17.45B	-15.56B	-15.13B	-15.77B
EBIT	-12.7B	-17.61B	-15.66B	-15.23B	-15.88B
EBITDAR	-10.03B	-14.34B	-	-	-
Effective Tax Rate - (Ratio)	-0.52	-0.26	1.58	0.03	0.12
Normalized Net Income	-11.02B	-11.35B	-9.55B	-9.31B	-9.96B
Supplemental Operating Expense Items
Advertising Expense	24.73M	7.09M	8.59M	15.58M	8.29M
Selling and Marketing Expenses	592M	1.35B	1.63B	1.42B	1.34B
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	9.84B	14.18B	14.84B	13.37B	11.44B
Net Rental Expense, Total	21.28M	2.69M	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Maintenance & Repair Expenses, Total	89.58M	127M	76.79M	49.15M	86.91M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	2.45B	67.97B	4.64B	5.04B	4.26B
Short Term Investments	15.1B	2.63B	23.5B	9.6B	718M
Trading Asset Securities, Total	23.61M	-	2.1B	2.6B	-
Total Cash And Short Term Investments	17.57B	70.6B	30.24B	17.24B	4.98B
Accounts Receivable, Total	70.67M	412M	387M	371M	415M
Other Receivables	58.47M	8.5M	249M	163M	29.85M
Notes Receivable	-	-	-	2.58B	999M
Total Receivables	129M	421M	636M	3.11B	1.44B
Inventory	24.05M	105M	705M	814M	172M
Prepaid Expenses	137M	330M	33.24M	185M	49.6M
Other Current Assets, Total	993M	660M	1.06B	1.93B	1.32B
Total Current Assets	18.86B	72.12B	32.67B	23.28B	7.97B
Gross Property Plant And Equipment	49.41B	53B	53.71B	61.04B	61.73B
Accumulated Depreciation	-9.11B	-12.24B	-15.64B	-20.29B	-23.04B
Net Property Plant And Equipment	40.3B	40.76B	38.07B	40.74B	38.68B
Long-term Investments	23.81M	82.09M	2.61B	2.62B	2.6B
Other Intangibles, Total	667M	647M	605M	675M	687M
Accounts Receivable Long-Term	-	-	-	340	-
Loans Receivable Long-Term	-	3.38B	2.68B	-	-
Deferred Charges Long-Term	234M	0	-	-	1.13B
Other Long-Term Assets, Total	900M	722M	1.23B	958M	1.43B
Total Assets	60.99B	118B	77.87B	68.27B	52.5B
Liabilities
Accounts Payable, Total	522M	725M	572M	642M	223M
Accrued Expenses, Total	178M	235M	220M	241M	307M
Short-term Borrowings	-	26.71B	-	3B	4.55B
Current Portion of Long-Term Debt	17.63M	-	3B	6.05B	-
Current Portion of Leases	-	97.04M	54.65M	94.95M	57.89M
Other Current Liabilities	408M	819M	2.76B	745M	1.75B
Total Current Liabilities	1.13B	28.59B	6.6B	10.77B	6.88B
Long-Term Debt	29.12B	9.05B	6.05B	-	4.5B
Long-Term Leases	23.4M	91.17M	52.26M	81.89M	26.1M
Pension & Other Post Retirement Benefits	2.04B	2.16B	2.32B	2.15B	2.67B
Deferred Tax Liability Non Current	317M	317M	92.54M	1.63B	1.55B
Other Non Current Liabilities	275M	368M	465M	534M	732M
Total Liabilities	32.9B	40.57B	15.59B	15.17B	16.37B
Preferred Stock Non Redeemable	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	7.66B	10.31B	10.31B	10.31B	10.31B
Additional Paid In Capital	67.64B	133B	133B	15.47B	15.75B
Retained Earnings	-48.53B	-67.07B	-82.05B	20.21B	4.89B
Treasury Stock	-	-	-	-	-891M
Comprehensive Income and Other	1.31B	1.36B	1.48B	7.12B	6.06B
Total Common Equity	28.09B	77.13B	62.28B	53.11B	36.13B
Total Equity	28.09B	77.13B	62.28B	53.11B	36.13B
Total Liabilities And Equity	60.99B	118B	77.87B	68.27B	52.5B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	15.33M	20.63M	20.63M	20.63M	20.55M
ECS Total Common Shares Outstanding	15.33M	20.63M	20.63M	20.63M	20.55M
Book Value / Share	1.83K	3.74K	3.02K	2.57K	1.76K
Tangible Book Value	27.42B	76.49B	61.68B	52.43B	35.44B
Tangible Book Value Per Share	1.79K	3.71K	2.99K	2.54K	1.72K
Total Debt	29.16B	35.95B	9.16B	9.23B	9.13B
Net Debt	11.59B	-34.65B	-21.08B	-8.02B	4.15B
Debt Equivalent Oper. Leases	170M	21.51M	-	-	-
Inventories - Raw Materials, Total	41.14M	36.76M	29.46M	52.16M	53.55M
Inventories - Work In Process, Total	-	-	374M	425M	-
Inventories - Finished Goods, Total	-	84.96M	318M	354M	136M
Inventories - Others	-190	-660	-680	-800	-640
Land - (BS)	8.99B	8.99B	15.47B	22.57B	22.7B
Buildings, Total	11.72B	12.01B	12.01B	12.13B	12.13B
Machinery, Total	10.66B	10.83B	10.87B	11.42B	11.51B
Accumulated Allowance for Doubtful Accounts (Supple)	27.72M	526K	526K	526K	526K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-17.72B	-18.38B	-15.04B	-15.06B	-15.92B
Depreciation & Amortization - CF	2.5B	3.11B	3.41B	4.95B	2.78B
Amortization of Goodwill and Intangible Assets - (CF)	152M	154M	102M	101M	118M
Depreciation & Amortization, Total	2.65B	3.27B	3.51B	5.05B	2.89B
(Gain) Loss From Sale Of Asset	-2M	1K	913K	162M	-3.47M
(Gain) Loss on Sale of Investments - (CF)	-101K	-	-5.28M	-7.1M	-2.83M
Asset Writedown & Restructuring Costs	-	173M	15.96M	19.49M	7.05M
Stock-Based Compensation (CF)	234M	48.5M	128M	97.61M	8.31M
Provision and Write-off of Bad Debts	526K	-	-	-	-
Other Operating Activities, Total	6.33B	1.47B	-130M	669M	869M
Change In Accounts Receivable	-31.14M	-341M	24.54M	16.86M	-44.26M
Change In Inventories	1.03M	-80.57M	-600M	-109M	641M
Change In Accounts Payable	312M	203M	-154M	70.7M	-418M
Change in Other Net Operating Assets	-1.38B	93.83M	1.64B	-2.63B	997M
Cash from Operations	-9.6B	-13.55B	-10.61B	-11.72B	-10.97B
Capital Expenditure	-5.01B	-3.1B	-699M	-1.52B	-731M
Sale of Property, Plant, and Equipment	2M	-	-	836M	19.86M
Sale (Purchase) of Intangible assets	-99.2M	-73.02M	-76.17M	-191M	-1.26B
Investment in Marketable and Equity Securities, Total	14.1B	12.44B	-25.49B	13.4B	11.5B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-3.38B	701M	95.41M	1.58B
Other Investing Activities, Total	200M	-412M	-310M	-542M	-70M
Cash from Investing	9.2B	5.48B	-25.88B	12.07B	11.04B
Long-Term Debt Issued, Total	3B	6.05B	-	-	-
Total Debt Issued	3B	6.05B	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-2.02B	-68.77M	-26.98B	-102M	-101M
Total Debt Repaid	-2.02B	-68.77M	-26.98B	-102M	-101M
Issuance of Common Stock	-	68.9B	-	-	-
Repurchase of Common Stock	-	-	-	-	-891M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	47.5M	-1.28B	80.51M	54.38M	139M
Cash from Financing	1.03B	73.61B	-26.9B	-47.81M	-853M
Foreign Exchange Rate Adjustments	23.94M	-12M	64.87M	95.9M	12.06M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	650M	65.52B	-63.33B	402M	-775M
Supplemental Items
Cash Interest Paid	126M	219M	254M	273M	379M
Cash Income Tax Paid (Refund)	45.86M	-83.09M	320M	41.99M	-19.73M
Levered Free Cash Flow	-10.79B	-10.47B	-6.23B	-11.88B	-5.57B
Unlevered Free Cash Flow	-10.79B	-10.47B	-6.2B	-11.7B	-5.32B
Change In Net Working Capital	396M	-439M	-849M	5.52B	-3.71B
Net Debt Issued / Repaid	982M	5.98B	-26.98B	-102M	-101M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-11.96	-12.32	-10.01	-13.02	-16.44
Return on Total Capital	-12.58	-12.92	-10.61	-14.23	-18.45
Return On Equity %	-48.42	-34.94	-21.58	-26.11	-35.68
Return on Common Equity	-48.42	-34.94	-21.58	-26.11	-35.68
Margin Analysis
Gross Profit Margin %	31.48	32.36	67.42	56.26	31.53
SG&A Margin	179.94	134.31	75.54	83.6	155.99
EBITDA Margin %	-558.12	-459.5	-183.39	-174.96	-388.69
EBITA Margin %	-696.9	-559.22	-234.83	-260.16	-471.76
EBIT Margin %	-705.32	-564.17	-236.37	-261.9	-475.3
Income From Continuing Operations Margin %	-983.7	-589.03	-227.07	-259.08	-476.43
Net Income Margin %	-983.7	-589.03	-227.07	-259.08	-476.43
Net Avail. For Common Margin %	-983.7	-589.03	-227.07	-259.08	-476.43
Normalized Net Income Margin	-611.71	-363.74	-144.09	-160.09	-298.11
Levered Free Cash Flow Margin	-599.13	-335.48	-93.98	-204.29	-166.62
Unlevered Free Cash Flow Margin	-599.13	-335.48	-93.64	-201.28	-159.22
Asset Turnover
Asset Turnover	0.03	0.03	0.07	0.08	0.06
Fixed Assets Turnover	0.05	0.08	0.17	0.15	0.08
Receivables Turnover (Average Receivables)	32.54	12.93	16.57	15.33	8.51
Inventory Turnover (Average Inventory)	50.22	32.81	5.33	3.35	4.64
Short Term Liquidity
Current Ratio	16.75	2.52	4.95	2.16	1.16
Quick Ratio	15.72	2.48	4.68	1.65	0.79
Operating Cash Flow to Current Liabilities	-8.53	-0.47	-1.61	-1.09	-1.59
Days Sales Outstanding (Average Receivables)	11.22	28.31	22.03	23.8	42.9
Days Outstanding Inventory (Average Inventory)	7.27	11.16	68.46	108.96	78.62
Average Days Payable Outstanding	108.34	104.18	85.81	83.49	95.85
Cash Conversion Cycle (Average Days)	-89.86	-64.72	4.68	49.27	25.67
Long Term Solvency
Total Debt/Equity	103.83	46.6